Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Xenogen (XGEN) -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (28)	8/12/2005 2:43:05 AM
From: tuck	Read Replies (1) \| Respond to of 45

Whoa, now a private placement with all the stuff I feared! >>ALAMEDA, Calif., Aug. 11 /PRNewswire-FirstCall/ -- Xenogen Corporation (Nasdaq: XGEN - News) announced today that it has entered into definitive agreements to sell $15 million of its common stock and warrants exercisable for additional shares of common stock. The securities are being sold to accredited institutional and venture investors and the parties expect to close the transaction shortly. Xenogen has agreed to sell 5,154,639 shares of its common stock at $2.91 per share, a $0.05 premium to the closing price of the common stock on August 11, 2005. The sale includes 30% warrant coverage at an exercise price of $3.29 per share, a 15% premium to the common stock closing price on August 11, 2005. The proceeds of the financing are expected to be used for working capital and general corporate purposes.<< snip I have not seen the warrants termed this way: "30% warrant coverage." Meaning .3*5,154,639= warrants for 1,546,392 shares? No 8-K for this, and 10-Q yet, either. Reminds of Rigel. Is the worst about over? Cheers, Tuck